Objective: Assess if a classroom-based pharmacy education service for hospitalized headache patients newly prescribed a monoamine oxidase inhibitor (MAOI) results in, 1) higher self-perceived medication knowledge, or 2) lower perceived risk of using MAOIs.
Subjects: Individuals admitted to an inpatient headache unit over a five month period
Methods: Patient survey administered before and after the education service to any patient newly prescribed an MAOI.
Results: Seventy-eight individuals completed the study. Paired-samples t-tests showed that for each of the four items related to self-perceived medication knowledge, the scores reflected higher knowledge after the MAOI class compared to before the class (p < 0.05). For three out of the four items related to perceived risk of using MAOIs, the scores reflected a lower level of perceived risk after the MAOI class compared to before the class (p < 0.05). One item did not significantly change: “The MAOI prescribed for me is just as good as other products available for treating headache.”
Conclusion: Our results demonstrate a pharmacist-conducted, classroom-based teaching method for newly prescribed MAOI patients can result in higher self-perceived medication knowledge and lower perceived risks.
Wenzel RG, Schommer JC. Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based Education. Innov. Pharm. 2010; 1(5): 1-7.
Volume 01, Number 1, 2010
Wenzel, Richard G.; Schommer, Jon C..
Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based Education.
University of Minnesota, College of Pharmacy.
Retrieved from the University of Minnesota Digital Conservancy,
Content distributed via the University of Minnesota's Digital Conservancy may be subject to additional license and use restrictions applied by the depositor.